094 Platelet-Rich Plasma and Stem Cell Therapy for Erectile Dysfunction: Characterization of Market Forces in a Major Metropolitan Area

2021 ◽  
Vol 18 (3) ◽  
pp. S50
Author(s):  
R. Shahinyan ◽  
J. Weinberger ◽  
C. Shangyang ◽  
J. Mills ◽  
S. Eleswarapu
2008 ◽  
Vol 8 (10) ◽  
pp. 1521-1538 ◽  
Author(s):  
Serap Gur ◽  
Philip J Kadowitz ◽  
Wayne JG Hellstrom

2018 ◽  
Vol 18 (11) ◽  
pp. 1137-1150 ◽  
Author(s):  
Serap Gur ◽  
Asim B Abdel-Mageed ◽  
Suresh C. Sikka ◽  
Wayne J.G. Hellstrom

2012 ◽  
Vol 21 (3) ◽  
pp. 343-351 ◽  
Author(s):  
Ching-Shwun Lin ◽  
Zhong-Cheng Xin ◽  
Zhong Wang ◽  
Chunhua Deng ◽  
Yun-Ching Huang ◽  
...  

2019 ◽  
Vol 32 (3) ◽  
pp. 308-316 ◽  
Author(s):  
Ömercan Albayrak ◽  
Tarık Emre Şener ◽  
Mehmet Erşahin ◽  
Suna Özbaş-Turan ◽  
Ceyda Ekentok ◽  
...  

2019 ◽  
Vol 14 (3) ◽  
pp. 226-229 ◽  
Author(s):  
Wei Zhou ◽  
Ming Qu ◽  
Yajie Lv ◽  
Jinyu Zhu

Osteonecrosis of the femoral head (ONFH) is a common refractory orthopedic disease with multiple etiologies that more frequently occurs in middle-aged and young people. ONFH is the main cause of hip replacement in young patients. Since Professor Hernigou first reported the use of stem cells in the treatment of early stage ONFH, a large number of studies have demonstrated the potential of stem cells in the treatment of adult patients with ONFH. With the rise of interdisciplinary stem cell therapy combined with platelet-rich plasma therapy, gene therapy or other methods have gradually attracted the attention of researchers. This article summarizes the current advances in stem cell therapy for ONFH, as well as the problems and challenges, which may provide reference for further research.


2012 ◽  
Vol 9 (8) ◽  
pp. 435-447 ◽  
Author(s):  
Martin Vaegler ◽  
Andrew T. Lenis ◽  
Lisa Daum ◽  
Bastian Amend ◽  
Arnulf Stenzl ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document